Aseptic clarification and purification of vaccines,monoclonal antibodies, recombinant proteins, and plasmids. Aseptic cell processing. Environments where terminal sterilization is not feasible. Preclinical through Phase II clinical trials. Fast-track drug development processes.
Biological Reactivity Test, In Vivo per USP 88 Class VI L929 MEM Elution Test – ISO 10993-5 (Cytotoxicity) Hemolysis – Rabbit Blood (direct contact) – ISO 10993-4 Manufactured with materials that comply with EMEA/410/01
Required Cross Flow Rate (at 2000/sec) lpm
600
Required Cross Flow Rate (at 4000/sec) lpm
1200
Required Cross Flow Rate (at 8000/sec) lpm
2500
Required Cross Flow Rate (at 16000/sec) lpm
5000
Operating Temp.
Up to 40°C
Sanitization Conditions
Pre-sterilized via gamma radiation
pH Stability Short Term
4–10
Certificate of Analysis
Yes
1 mm,60 cm,750000 NMWC,0.085 m2 (0.9 ft2)
¥22,826.00
RTPUFP-50-C-4MS
产品详情
0.5 mm,30 cm,50000 NMWC,0.065 m2 (0.7 ft2)
无菌 ReadyToProcess 中空纤维滤器 50 kD,纤维内径 0.5 mm,4 M 号外壳,AdvantaPure 管
生物反应性试验,活体试验,根据 USP 88 VI 级 L929 MEM 洗脱试验 – ISO 10993-5(细胞毒性) 溶血 – 兔血(直接接触)– ISO 10993-4 使用符合 EMEA/410/01 的材料制造
所需的切向流速(2000/秒)lpm
1.1
所需的切向流速(4000/秒)lpm
2.1
所需的切向流速(8000/秒)lpm
4.3
所需的切向流速(16000/秒)lpm
8.6
操作温度
最高 40°C
消毒条件
通过伽玛射线预灭菌
pH 值短期稳定性
4–10
质检报告
是
0.5 mm,30 cm,10,000 NMWC,0.2 m2 (2.1 ft2)
¥26,329.00
RTPUFP-100-C-4MS
产品详情
0.5 mm,30 cm,100000 NMWC,0.065 m2 (0.7 ft2)
无菌 ReadyToProcess 中空纤维滤器 100 kD,纤维内径 0.5 mm,4 M 号外壳,AdvantaPure 管
Application
Aseptic clarification and purification of vaccines,monoclonal antibodies, recombinant proteins, and plasmids. Aseptic cell processing. Environments where terminal sterilization is not feasible. Preclinical through Phase II clinical trials. Fast-track drug development processes.
Biological Reactivity Test, In Vivo per USP 88 Class VI L929 MEM Elution Test – ISO 10993-5 (Cytotoxicity) Hemolysis – Rabbit Blood (direct contact) – ISO 10993-4 Manufactured with materials that comply with EMEA/410/01
Aseptic clarification and purification of vaccines,monoclonal antibodies, recombinant proteins, and plasmids. Aseptic cell processing. Environments where terminal sterilization is not feasible. Preclinical through Phase II clinical trials. Fast-track drug development processes.
Biological Reactivity Test, In Vivo per USP 88 Class VI L929 MEM Elution Test – ISO 10993-5 (Cytotoxicity) Hemolysis – Rabbit Blood (direct contact) – ISO 10993-4 Manufactured with materials that comply with EMEA/410/01
Required Cross Flow Rate (at 2000/sec) lpm
1.1
Required Cross Flow Rate (at 4000/sec) lpm
2.1
Required Cross Flow Rate (at 8000/sec) lpm
4.3
Required Cross Flow Rate (at 16000/sec) lpm
8.6
Operating Temp.
Up to 40°C
Sanitization Conditions
Pre-sterilized via gamma radiation
pH Stability Short Term
4–10
Certificate of Analysis
Yes
0.5 mm,30 cm,100000 NMWC,0.2 m2 (2.1 ft2)
¥26,329.00
RTPUFP-10-C-4MS
产品详情
0.5 mm,30 cm,10,000 NMWC,0.065 m2 (0.7 ft2)
无菌 ReadyToProcess 中空纤维滤器 10 kD,纤维内径 0.5 mm,4 M 号外壳,AdvantaPure 管
生物反应性试验,活体试验,根据 USP 88 VI 级 L929 MEM 洗脱试验 – ISO 10993-5(细胞毒性) 溶血 – 兔血(直接接触)– ISO 10993-4 使用符合 EMEA/410/01 的材料制造
所需的切向流速(2000/秒)lpm
300
所需的切向流速(4000/秒)lpm
600
所需的切向流速(8000/秒)lpm
1200
所需的切向流速(16000/秒)lpm
2400
操作温度
最高 40°C
消毒条件
通过伽玛射线预灭菌
pH 值短期稳定性
4–10
质检报告
是
0.5 mm,30 cm,10,000 NMWC,0.065 m2 (0.7 ft2)
¥18,306.00
RTPUFP-30-C-4MS
产品详情
0.5 mm,30 cm,30000 NMWC,0.065 m2 (0.7 ft2)
无菌 ReadyToProcess 中空纤维滤器 30 kD,纤维内径 0.5 mm,4 M 号外壳,AdvantaPure 管
Application
Aseptic clarification and purification of vaccines,monoclonal antibodies, recombinant proteins, and plasmids. Aseptic cell processing. Environments where terminal sterilization is not feasible. Preclinical through Phase II clinical trials. Fast-track drug development processes.
Biological Reactivity Test, In Vivo per USP 88 Class VI L929 MEM Elution Test – ISO 10993-5 (Cytotoxicity) Hemolysis – Rabbit Blood (direct contact) – ISO 10993-4 Manufactured with materials that comply with EMEA/410/01
生物反应性试验,活体试验,根据 USP 88 VI 级 L929 MEM 洗脱试验 – ISO 10993-5(细胞毒性) 溶血 – 兔血(直接接触)– ISO 10993-4 使用符合 EMEA/410/01 的材料制造
所需的切向流速(2000/秒)lpm
2.7
所需的切向流速(4000/秒)lpm
5.4
所需的切向流速(8000/秒)lpm
10.6
所需的切向流速(16000/秒)lpm
21.5
操作温度
最高 40°C
消毒条件
通过伽玛射线预灭菌
pH 值短期稳定性
4–10
质检报告
是
0.5 mm,30 cm,300000 NMWC,0.53 m2 (5.7 ft2)
¥35,708.00
RTPUFP-300-C-4MS
产品详情
0.5 mm,30 cm,300000 NMWC,0.065 m2 (0.7 ft2)
无菌 ReadyToProcess 中空纤维滤器 300 kD,纤维内径 0.5 mm,4 M 号外壳,AdvantaPure 管
应用
Aseptic clarification and purification of vaccines,monoclonal antibodies, recombinant proteins, and plasmids. Aseptic cell processing. Environments where terminal sterilization is not feasible. Preclinical through Phase II clinical trials. Fast-track drug development processes.
Biological Reactivity Test, In Vivo per USP 88 Class VI L929 MEM Elution Test – ISO 10993-5 (Cytotoxicity) Hemolysis – Rabbit Blood (direct contact) – ISO 10993-4 Manufactured with materials that comply with EMEA/410/01
所需的切向流速(2000/秒)lpm
300
所需的切向流速(4000/秒)lpm
600
所需的切向流速(8000/秒)lpm
1200
所需的切向流速(16000/秒)lpm
2400
操作温度
Up to 40°C
消毒条件
Pre-sterilized via gamma radiation
pH 值短期稳定性
4–10
质检报告
是
0.5 mm,30 cm,300000 NMWC,0.065 m2 (0.7 ft2)
¥18,306.00
RTPUFP-500-C-4MS
产品详情
0.5 mm,30 cm,500000 NMWC,0.065 m2 (0.7 ft2)
无菌 ReadyToProcess 中空纤维滤器 500 kD,纤维内径 0.5 mm,4 M 号外壳,AdvantaPure 管
Application
Aseptic clarification and purification of vaccines,monoclonal antibodies, recombinant proteins, and plasmids. Aseptic cell processing. Environments where terminal sterilization is not feasible. Preclinical through Phase II clinical trials. Fast-track drug development processes.
Biological Reactivity Test, In Vivo per USP 88 Class VI L929 MEM Elution Test – ISO 10993-5 (Cytotoxicity) Hemolysis – Rabbit Blood (direct contact) – ISO 10993-4 Manufactured with materials that comply with EMEA/410/01
Aseptic clarification and purification of vaccines,monoclonal antibodies, recombinant proteins, and plasmids. Aseptic cell processing. Environments where terminal sterilization is not feasible. Preclinical through Phase II clinical trials. Fast-track drug development processes.
Biological Reactivity Test, In Vivo per USP 88 Class VI L929 MEM Elution Test – ISO 10993-5 (Cytotoxicity) Hemolysis – Rabbit Blood (direct contact) – ISO 10993-4 Manufactured with materials that comply with EMEA/410/01
Aseptic clarification and purification of vaccines,monoclonal antibodies, recombinant proteins, and plasmids. Aseptic cell processing. Environments where terminal sterilization is not feasible. Preclinical through Phase II clinical trials. Fast-track drug development processes.
Biological Reactivity Test, In Vivo per USP 88 Class VI L929 MEM Elution Test – ISO 10993-5 (Cytotoxicity) Hemolysis – Rabbit Blood (direct contact) – ISO 10993-4 Manufactured with materials that comply with EMEA/410/01
Aseptic clarification and purification of vaccines,monoclonal antibodies, recombinant proteins, and plasmids. Aseptic cell processing. Environments where terminal sterilization is not feasible. Preclinical through Phase II clinical trials. Fast-track drug development processes.
Biological Reactivity Test, In Vivo per USP 88 Class VI L929 MEM Elution Test – ISO 10993-5 (Cytotoxicity) Hemolysis – Rabbit Blood (direct contact) – ISO 10993-4 Manufactured with materials that comply with EMEA/410/01
Aseptic clarification and purification of vaccines,monoclonal antibodies, recombinant proteins, and plasmids. Aseptic cell processing. Environments where terminal sterilization is not feasible. Preclinical through Phase II clinical trials. Fast-track drug development processes.
Biological Reactivity Test, In Vivo per USP 88 Class VI L929 MEM Elution Test – ISO 10993-5 (Cytotoxicity) Hemolysis – Rabbit Blood (direct contact) – ISO 10993-4 Manufactured with materials that comply with EMEA/410/01
Aseptic clarification and purification of vaccines,monoclonal antibodies, recombinant proteins, and plasmids. Aseptic cell processing. Environments where terminal sterilization is not feasible. Preclinical through Phase II clinical trials. Fast-track drug development processes.
Biological Reactivity Test, In Vivo per USP 88 Class VI L929 MEM Elution Test – ISO 10993-5 (Cytotoxicity) Hemolysis – Rabbit Blood (direct contact) – ISO 10993-4 Manufactured with materials that comply with EMEA/410/01
Aseptic clarification and purification of vaccines,monoclonal antibodies, recombinant proteins, and plasmids. Aseptic cell processing. Environments where terminal sterilization is not feasible. Preclinical through Phase II clinical trials. Fast-track drug development processes.
Biological Reactivity Test, In Vivo per USP 88 Class VI L929 MEM Elution Test – ISO 10993-5 (Cytotoxicity) Hemolysis – Rabbit Blood (direct contact) – ISO 10993-4 Manufactured with materials that comply with EMEA/410/01
Aseptic clarification and purification of vaccines,monoclonal antibodies, recombinant proteins, and plasmids. Aseptic cell processing. Environments where terminal sterilization is not feasible. Preclinical through Phase II clinical trials. Fast-track drug development processes.
Biological Reactivity Test, In Vivo per USP 88 Class VI L929 MEM Elution Test – ISO 10993-5 (Cytotoxicity) Hemolysis – Rabbit Blood (direct contact) – ISO 10993-4 Manufactured with materials that comply with EMEA/410/01
Aseptic clarification and purification of vaccines,monoclonal antibodies, recombinant proteins, and plasmids. Aseptic cell processing. Environments where terminal sterilization is not feasible. Preclinical through Phase II clinical trials. Fast-track drug development processes.
Biological Reactivity Test, In Vivo per USP 88 Class VI L929 MEM Elution Test – ISO 10993-5 (Cytotoxicity) Hemolysis – Rabbit Blood (direct contact) – ISO 10993-4 Manufactured with materials that comply with EMEA/410/01
Aseptic clarification and purification of vaccines,monoclonal antibodies, recombinant proteins, and plasmids. Aseptic cell processing. Environments where terminal sterilization is not feasible. Preclinical through Phase II clinical trials. Fast-track drug development processes.
Biological Reactivity Test, In Vivo per USP 88 Class VI L929 MEM Elution Test – ISO 10993-5 (Cytotoxicity) Hemolysis – Rabbit Blood (direct contact) – ISO 10993-4 Manufactured with materials that comply with EMEA/410/01
Aseptic clarification and purification of vaccines,monoclonal antibodies, recombinant proteins, and plasmids. Aseptic cell processing. Environments where terminal sterilization is not feasible. Preclinical through Phase II clinical trials. Fast-track drug development processes.
Biological Reactivity Test, In Vivo per USP 88 Class VI L929 MEM Elution Test – ISO 10993-5 (Cytotoxicity) Hemolysis – Rabbit Blood (direct contact) – ISO 10993-4 Manufactured with materials that comply with EMEA/410/01
Aseptic clarification and purification of vaccines,monoclonal antibodies, recombinant proteins, and plasmids. Aseptic cell processing. Environments where terminal sterilization is not feasible. Preclinical through Phase II clinical trials. Fast-track drug development processes.
Biological Reactivity Test, In Vivo per USP 88 Class VI L929 MEM Elution Test – ISO 10993-5 (Cytotoxicity) Hemolysis – Rabbit Blood (direct contact) – ISO 10993-4 Manufactured with materials that comply with EMEA/410/01
Aseptic clarification and purification of vaccines,monoclonal antibodies, recombinant proteins, and plasmids. Aseptic cell processing. Environments where terminal sterilization is not feasible. Preclinical through Phase II clinical trials. Fast-track drug development processes.
Biological Reactivity Test, In Vivo per USP 88 Class VI L929 MEM Elution Test – ISO 10993-5 (Cytotoxicity) Hemolysis – Rabbit Blood (direct contact) – ISO 10993-4 Manufactured with materials that comply with EMEA/410/01
Required Cross Flow Rate (at 2000/sec) lpm
1.1
Required Cross Flow Rate (at 4000/sec) lpm
2.1
Required Cross Flow Rate (at 8000/sec) lpm
4.3
Required Cross Flow Rate (at 16000/sec) lpm
8.6
Operating Temp.
Up to 40°C
Sanitization Conditions
Pre-sterilized via gamma radiation
pH Stability Short Term
4–10
Certificate of Analysis
Yes
0.5 mm,60 cm,500000 NMWC,0.48 m2 (5.2 ft2)
¥33,109.00
RTPUFP-750-E-4MS
产品详情
1 mm,30 cm,750000 NMWC,0.042 m2 (0.45 ft2)
无菌 ReadyToProcess 中空纤维滤器 750 kD,纤维内径 1 mm,4 M 号外壳,AdvantaPure 管
Aseptic clarification and purification of vaccines,monoclonal antibodies, recombinant proteins, and plasmids. Aseptic cell processing. Environments where terminal sterilization is not feasible. Preclinical through Phase II clinical trials. Fast-track drug development processes.
Biological Reactivity Test, In Vivo per USP 88 Class VI L929 MEM Elution Test – ISO 10993-5 (Cytotoxicity) Hemolysis – Rabbit Blood (direct contact) – ISO 10993-4 Manufactured with materials that comply with EMEA/410/01
Aseptic clarification and purification of vaccines,monoclonal antibodies, recombinant proteins, and plasmids. Aseptic cell processing. Environments where terminal sterilization is not feasible. Preclinical through Phase II clinical trials. Fast-track drug development processes.
Biological Reactivity Test, In Vivo per USP 88 Class VI L929 MEM Elution Test – ISO 10993-5 (Cytotoxicity) Hemolysis – Rabbit Blood (direct contact) – ISO 10993-4 Manufactured with materials that comply with EMEA/410/01